Voyager Life PLC - Director/PDMR Shareholding
Announcement provided by
Mendell Helium plc · MDH03/03/2023 07:00

3 March 2023
Voyager Life plc
("Voyager" or the "Company")
Director / PDMR Shareholding
Voyager, the health and wellness company manufacturing and supplying high-quality Cannabidiol (CBD), hemp seed oil and hemp-related products, announces that it was informed on 2 March 2023 that Eric Boyle, Non-executive Chairman, transferred his entire shareholding from his personal account to his SIPP account on the 2 March 2023.
Eric Boyle disposed of 800,000 ordinary shares of
Following the above, Eric Boyle's shareholding in the Company is unchanged.
This announcement contains inside information for the purposes of the
ENDS
Enquiries:
Voyager Life plc
Nick Tulloch, CEO
|
Tel: +44 (0) 1738 317 693
|
Cairn Financial Advisers LLP (AQSE Corporate Adviser)
Ludovico Lazzaretti/Liam Murray
|
Tel: +44 (0) 20 7213 0880 |
Stanford Capital Partners LLP (Broker)
Patrick Claridge
Bob Pountney
John Howes
|
+44 (0) 203 3650 3650
+44 (0) 203 3650 3651
+44 (0) 203 3650 3652 |
Notes to Editors:
About Voyager
Voyager was founded in 2020 and is based in
The Company's philosophy of plant-based health and wellness is embodied in its mission statement and hashtag of "Choose you". With an experienced team and a product line created in line with the
Through Voyager's bespoke skincare product creation and development division, voyagerCann, the Company also offers a full turnkey service to other CBD, skincare and cosmetics brands assisting them in developing and launching new products with manufacturing and distribution facilities in
Website and social media links:
Voyager:
https://www.instagram.com/voyagercbd/
https://twitter.com/voyagercbd
https://www.linkedin.com/company/voyager-cbd/
https://www.facebook.com/voyagercbd/
voyagerCann:
https://www.instagram.com/voyagercann/
https://twitter.com/voyagercann/
https://www.linkedin.com/company/voyagercann/
https://www.facebook.com/voyagercann/
1. |
Details of PDMR / person closely associated with them ("PCA") |
||
a) |
Name |
Eric Boyle |
|
2. |
Reason for the notification |
||
a) |
Position / status |
Non-executive Chairman |
|
b) |
Initial notification / amendment |
Initial notification |
|
3. |
Details of the issuer, |
||
a) |
Name |
Voyager Life plc |
|
b) |
LEI |
213800XIUQ3AHRZ6UF89 |
|
2. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
a) |
Description of the financial instrument |
Ordinary shares of |
|
b) |
Nature of the transaction |
Sale of 800,000 ordinary shares at a price of |
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
800,000 |
||
|
|
|
|
|
|
|
|
|
|
|
|
d) |
Aggregated information Aggregated volume Price |
N/A
|
|
e) |
Date of the transaction |
2 March 2023 |
|
f) |
Place of the transaction |
AQSE |
|
1. |
Details of PDMR / person closely associated with them ("PCA") |
||
a) |
Name |
Eric Boyle |
|
2. |
Reason for the notification |
||
a) |
Position / status |
Non-executive Chairman |
|
b) |
Initial notification / amendment |
Initial notification |
|
3. |
Details of the issuer, |
||
a) |
Name |
Voyager Life plc |
|
b) |
LEI |
213800XIUQ3AHRZ6UF89 |
|
2. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
a) |
Description of the financial instrument |
Ordinary shares of |
|
b) |
Nature of the transaction |
Purchase of 800,000 ordinary shares at a price of |
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
800,000 |
||
|
|
|
|
|
|
|
|
|
|
|
|
d) |
Aggregated information Aggregated volume Price |
N/A
|
|
e) |
Date of the transaction |
2 March 2023 |
|
f) |
Place of the transaction |
AQSE |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.